No needles required: The FDA approves an at-home flu vaccine
Sep 20, 2024 · The Food and Drug Administration has approved the first flu vaccine that people can administer to themselves at home. The agency on Friday gave the green light for people who have been...
FDA Approves Nasal Spray Influenza Vaccine for Self- or …
Sep 20, 2024 · “Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with...
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA …
2 days ago · Under the $1.4 billion co-licensing agreement, announced in May, Sanofi will have the sole right to use Novavax's existing Covid-19 vaccine in combination with its own flu vaccine.
FDA approves first flu vaccine that can be self-administered at …
Sep 20, 2024 · The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this ...
FDA approves first self-administered flu vaccine spray - CBS News
Sep 20, 2024 · The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the...
FDA approves first at-home flu vaccine in U.S., a nasal spray
Sep 20, 2024 · The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home administration. Starting in fall 2025, people who...
FDA’s Critical Role in Ensuring Safe and Effective Flu Vaccines
Oct 23, 2024 · The FDA and HHS are working on developing new and better technologies for producing flu vaccines. The flu vaccine you get is the year-round work of highly skilled microbiologists, epidemiologists ...
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine …
Aug 16, 2024 · Pfizer developed second-generation candidates with the goal of improving immunogenicity and potentially breadth of protection, including new tIRV formulations that matched updated recommendations by the World Health Organization (“WHO”) and the FDA’s Vaccines and Related Biological Products Advisory Committee (“VRBPAC”).
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for …
Dec 9, 2022 · NEW YORK and MAINZ, GERMANY, DECEMBER 9, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the companies have received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for their mRNA-based combination vaccine candidate for influenza and COVID-19, which aims to …
US FDA lifts clinical hold on Novavax's combo COVID-flu shot
2 days ago · Nov 11 (Reuters) - The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's , opens new tab COVID-influenza and its standalone flu vaccines, the ...